Millennium Management’s Foundation Medicine, Inc. FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-26,056
Closed -$1.78M 4328
2017
Q4
$1.78M Buy
+26,056
New +$1.35M ﹤0.01% 2357
2017
Q1
Sell
-33,981
Closed -$601K 4053
2016
Q4
$601K Sell
33,981
-9,071
-21% -$195K ﹤0.01% 2583
2016
Q3
$1M Sell
43,052
-213,611
-83% -$4.85M ﹤0.01% 2262
2016
Q2
$4.79M Buy
256,663
+42,685
+20% +$772K 0.01% 1287
2016
Q1
$3.89M Sell
213,978
-15,568
-7% -$251K 0.01% 1394
2015
Q4
$4.83M Sell
229,546
-137,401
-37% -$2.65M 0.01% 1381
2015
Q3
$6.77M Buy
366,947
+181,963
+98% +$4.54M 0.01% 1162
2015
Q2
$6.26M Buy
184,984
+162,651
+728% +$6.54M 0.01% 1252
2015
Q1
$1.07M Sell
22,333
-48,620
-69% -$2.21M ﹤0.01% 2272
2014
Q4
$1.58M Buy
70,953
+59,810
+537% +$1.38M ﹤0.01% 2162
2014
Q3
$211K Buy
11,143
+3,170
+40% +$75.6K ﹤0.01% 3387
2014
Q2
$215K Buy
+7,973
New +$202K ﹤0.01% 3081
2014
Q1
Sell
-44,136
Closed -$1.05M 4109
2013
Q4
$1.05M Buy
+44,136
New +$1.23M ﹤0.01% 2255

Other funds holding FMI

Millennium Management's FMI Position: Q1 2018 in Review

Millennium Management sold out of Foundation Medicine, Inc. (FMI) in Q1 2018, closing a stake of 26,056 shares — an estimated $1.78M sold.

Millennium Management first reported a position in FMI in Q4 2013 and held it in 13 quarters. The position peaked at $6.77M in Q3 2015. 144 funds tracked by Wall St. Rank hold FMI as of Q1 2018.

  • Millennium Management reported no remaining Foundation Medicine, Inc. position as of Q1 2018 after selling out during the quarter.
  • Millennium Management sold 26,056 Foundation Medicine, Inc. shares in Q1 2018, an estimated $1.78M.
  • Millennium Management first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 13 quarters.
  • Millennium Management's Foundation Medicine, Inc. position peaked at $6.77M in Q3 2015.
  • 144 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.